Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
65 hedge funds and large institutions have $150M invested in Tetraphase Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 8 closing their positions.
238% more call options, than puts
Call options by funds: $423K | Put options by funds: $125K
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
125% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 12
20% more funds holding
Funds holding: 54 → 65 (+11)
16% less capital invested
Capital invested by funds: $179M → $150M (-$29.4M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$8.73M |
| 2 |
Millennium Management
New York
|
+$7.61M |
| 3 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$4.25M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.85M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FV2GP
Flagship Ventures 2007 General Partner
Cambridge,
Massachusetts
|
-$15.8M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$4.18M |
| 3 |
BC
Broadfin Capital
New York
|
-$2.58M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.92M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.72M |
TTPH Hedge Fund Activity: Q1 2014 in Review
65 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2014, worth a combined $150M — down 16% from $179M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TTPH positions and 8 closed out — a net gain of 11 holders — while 27 added to existing stakes and 12 trimmed.
The largest buyer was PointState Capital, opening a new position worth an estimated $8.73M. The largest seller was Flagship Ventures 2007 General Partner, exiting entirely with an estimated $15.8M sold.
- 65 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2014, up from 54 in Q4 2013.
- Funds reported $150M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2014, down 16% quarter-over-quarter.
- 19 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2014 and 8 closed out, a net change of +11 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2014 was PointState Capital, an estimated $8.73M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2014 was Flagship Ventures 2007 General Partner, an estimated $15.8M sold.
Based on aggregated 13F filings for Q1 2014.